Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
73.88 CHF | -1.27% | +5.32% | 0.00% |
May. 15 | Ten key beauty players | |
May. 10 | Europe sees two-speed IPO recovery as smaller deals lag | RE |
Sales 2024 * | 4.43B 4.03B | Sales 2025 * | 4.96B 4.51B | Capitalization | 19.36B 17.6B |
---|---|---|---|---|---|
Net income 2024 * | 218M 198M | Net income 2025 * | 468M 425M | EV / Sales 2024 * | 4.89 x |
Net Debt 2024 * | 2.31B 2.1B | Net Debt 2025 * | 1.81B 1.64B | EV / Sales 2025 * | 4.27 x |
P/E ratio 2024 * |
92.4
x | P/E ratio 2025 * |
39.3
x | Employees | - |
Yield 2024 * |
0.07% | Yield 2025 * |
0.34% | Free-Float | 0% |
Latest transcript on Galderma Group AG
1 day | -1.27% | ||
1 week | +5.32% | ||
Current month | +7.85% | ||
1 month | +16.16% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 73.88 | -1.27% | 152,399 |
24-05-16 | 74.83 | +2.51% | 304,091 |
24-05-15 | 73 | +2.33% | 205,630 |
24-05-14 | 71.34 | +1.91% | 285,431 |
24-05-13 | 70 | -0.21% | 134,250 |
Delayed Quote Swiss Exchange, May 17, 2024 at 11:30 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 19.36B | |
-0.68% | 260B | |
+19.72% | 20.77B | |
+15.62% | 12.64B | |
-14.17% | 9.2B | |
+10.20% | 5.98B | |
-2.43% | 4.46B | |
-13.55% | 3.99B | |
-5.97% | 3.65B | |
-4.76% | 3.6B |
- Stock Market
- Equities
- GALD Stock